One Capital Management LLC raised its stake in The Cigna Group (NYSE:CI – Free Report) by 0.8% during the fourth quarter, Holdings Channel reports. The firm owned 39,339 shares of the health services provider’s stock after purchasing an additional 324 shares during the period. One Capital Management LLC’s holdings in The Cigna Group were worth $10,863,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in CI. Collier Financial purchased a new position in shares of The Cigna Group in the 4th quarter valued at $32,000. ORG Wealth Partners LLC purchased a new position in shares of The Cigna Group in the 4th quarter valued at $34,000. Prospera Private Wealth LLC purchased a new position in shares of The Cigna Group in the 3rd quarter valued at $37,000. Compagnie Lombard Odier SCmA purchased a new position in shares of The Cigna Group in the 4th quarter valued at $37,000. Finally, Harbor Capital Advisors Inc. purchased a new position in shares of The Cigna Group in the 3rd quarter valued at $45,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.
The Cigna Group Trading Up 0.3 %
Shares of The Cigna Group stock opened at $309.84 on Thursday. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $86.18 billion, a P/E ratio of 25.31, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The company has a 50-day simple moving average of $291.31 and a 200 day simple moving average of $318.05.
The Cigna Group Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be issued a $1.51 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.95%. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio is 49.35%.
Insider Activity
In other news, insider Nicole S. Jones sold 4,904 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the completion of the sale, the insider now owns 29,421 shares of the company’s stock, valued at $9,065,198.52. This trade represents a 14.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO David Cordani sold 26,527 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares of the company’s stock, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.
Analyst Ratings Changes
CI has been the topic of a number of research reports. Barclays cut their target price on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a research note on Friday, January 31st. Stephens dropped their price target on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a research note on Friday, January 31st. Truist Financial decreased their price objective on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a report on Tuesday, February 4th. Sanford C. Bernstein lowered shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price objective for the company. in a report on Thursday, February 6th. Finally, UBS Group decreased their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $372.31.
View Our Latest Stock Analysis on CI
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
- Five stocks we like better than The Cigna Group
- Short Selling – The Pros and Cons
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- There Are Different Types of Stock To Invest In
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Insider Trading – What You Need to Know
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.